Synthesis of Novel Pharmaceutical Synthons (Spirooxindoles) (No. 0023)

 
<< Back to all technologies

Summary

The chiral spirooxindole scaffold is present in a variety of bioactive alkaloids. Synthetic spirooxindoles have also been widely investigated for their anticancer, anti-inflammatory and analgesic activity, among others, with many drug candidates being tested in clinical trials with promising prospects. However, current metal-catalyzed synthetic methods involve complicated reaction conditions, whereas the aldol reaction of ketones to form quaternary carbon centers rarely affords high yields and stereoselectivity because of the reaction’s reversibility. A team of OIST researchers led by Prof. Fujie Tanaka has developed a novel synthetic approach to overcome the above problems and efficiently and stereoselectively synthesize novel spirooxindole derivatives from easily accessible starting materials under mild conditions.

 

Lead Researcher:
Fujie Tanaka

Faculty of Chemistry and Chemical Bioengineering Unit

Applications

  • Bioactive compounds
  • Drug development

 

Advantages

  • High yield and stereoselectivity
  • Mild conditions
  • One-pot reaction

An example of the catalytic hetero Diels-Alder reaction strategy

The catalysts promote oxy-Michael addition following the aldol step, driving the equilibrium of the aldol reaction

Click on the images to enlarge

 

Technology

In this protocol, enones are used as enamine-forming reactants and the catalyst systems were developed to allow oxy-Michael addition after the aldol step. Because of the one pot aldol-oxy-Michael reaction (or formal hetero-Diels-Alder reaction), the stereoselectivity of the aldol step can be retained. This synthetic strategy is the first example of organocatalytic asymmetric aldol-oxy-Michael reactions and enables the synthesis of functionalized tetrahydropyran derivatives bearing quaternary carbon centers in high yields and with high diastereo- and enantioselectivities under mild conditions.

 

Media Coverage and Presentations

 

CONTACT FOR MORE INFORMATION

  Paola Butler-Zanetti
Technology Licensing Section

  tls@oist.jp
  +81(0)98-966-8937